Condition
Coronary Heart Disease clinical trials and research
As of November 12, 2026, Find a Trial lists 27 Coronary Heart Disease clinical trials that are recruiting, at sites in 15 countries (most in China (12), United States (2), Finland (2)). By phase: Phase 4 (3), Early Phase 1 (1), Phase 2 (1), Phase 1/2 (1). There are also 12 NIH-funded research projects on Coronary Heart Disease, with $8.2 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 27Clinical trials
- 12NIH research projects
- 15Countries
Newest Coronary Heart Disease clinical trials
All recruiting trials (27)
-
NMR-based Risk Test and Digital Health Support for midlife adults in Eloisa
This study tests whether an NMR metabolomics risk test can guide tailored digital health programs for midlife adults at risk of diabetes, heart disease, stroke, kidney disease, or fatty liver.
-
Prospective cardiac surgery cohort to improve perioperative care
A multi-center study will test a large, forward-looking database of adults undergoing heart surgery to better understand what affects short- and long-term outcomes.
-
Mazdutide and coronary plaque in people with coronary artery disease and overweight or obesity
This study tests whether mazdutide can slow or reduce coronary plaque build-up in adults with coronary artery disease who are overweight or obese.
-
Understanding risk factors for cognitive problems in people with coronary heart disease
In people with coronary heart disease, this study tests how metabolic factors and imaging features relate to cognitive impairment.
-
Yiyang Huoluo Decoction for coronary heart disease with atherosclerosis in older adults
This study will test whether adding the Yiyang Huoluo herbal decoction to standard heart care helps people aged 50–75 with coronary heart disease and atherosclerosis.
-
Glycocalyx and oxidative stress in blood vessel lining during coronary bypass surgery
This project will see if changes in the endothelial glycocalyx and oxidative stress markers relate to microvascular function and outcomes in adults having elective coronary artery bypass grafting.
-
One-month vessel healing after BioFreedom polymer-free drug-coated stent versus Xience drug-eluting stent in heart attack patients with high bleeding risk
We'll use very detailed optical imaging to see if the polymer-free BioFreedom stent leads to faster or better vessel healing than the Xience stent in people with a recent heart attack who are at high bleeding risk.
-
CTCA before invasive angiography in people with prior CABG
This study tests whether a CTCA-guided plan before invasive angiography can reduce major heart-related events in people who had CABG and now have chest pain or a heart attack.
-
Sivelestat sodium treatment after off-pump coronary artery bypass grafting (OPCABG)
This trial will test whether giving sivelestat sodium after off-pump coronary bypass surgery helps protect the heart and reduce inflammation in adults having OPCABG.
-
Yangxinshi tablets for people with coronary heart disease and heart dysfunction
This trial tests whether adding Yangxinshi tablets to usual care helps people aged 40–80 with coronary heart disease and cardiac dysfunction have fewer heart-related events and better exercise tolerance and quality of life.
-
Innovative approaches for personalized cardiovascular prevention
This study is testing if using genetic information and smartwatches can help people make healthier choices to prevent heart disease.
-
Cognitive Behavioral Therapy for Insomnia in Heart Disease Patients
This study tests whether Cognitive Behavioral Therapy for Insomnia can help people with heart disease sleep better and improve their heart health.
-
Individualized exercise program for elderly patients with coronary heart disease
This study tests whether a personalized exercise program can help older patients with coronary heart disease feel better physically and mentally.
-
Exercise training for women with heart disease
This project will test whether virtual high-intensity interval training (HIIT) or virtual moderate-to-vigorous continuous training (MICT) better improves fitness, mental health, and quality of life in women with coronary heart disease.
-
Xuesaitong soft capsules to lower inflammation and improve risk markers in people with coronary heart disease
This trial tests whether Xuesaitong soft capsules lower hsCRP and improve other cardiovascular risk markers in adults with stable coronary heart disease who are already on statins and antiplatelet therapy.
-
Assessing cardiovascular and kidney health using metabolomics in patients with heart disease
This study is testing if certain fat-related substances in the blood can help predict health outcomes for adults with both heart disease and kidney problems.
-
Thiamine treatment for cognitive issues after heart surgery
This study is testing if giving thiamine to patients with heart disease after heart surgery can help improve their thinking and memory skills.
-
Lifestyle medicine program to help rural adults with multiple chronic conditions
This program will try supervised exercise and lifestyle coaching for rural adults aged 18–64 who have two or more chronic conditions to see if access to a wellness facility improves their health.
-
Evaluating biomarkers for coronary heart disease prognosis
This study is trying to find out which blood and stool markers can help predict health outcomes for people with coronary heart disease over two years.
-
Research on heart and kidney disease interactions
This study looks at how heart and kidney problems affect each other to find better treatment options for people with cardiorenal syndrome.
-
Exploring the link between unstable angina and anxiety-depressive syndrome
This study looks at how unstable angina and anxiety or depression are connected in people with heart disease by checking their blood for certain markers.
-
Personalized prevention program for patients with high-risk stable coronary heart disease
This study is testing a personalized prevention program to see if it can help people with high-risk stable coronary heart disease avoid heart problems better than regular care.
-
Research on health inequality and genetic disparity in cardiovascular diseases
This study is trying to understand how health differences and genetics affect heart diseases in people from various ethnic backgrounds in the UK to help improve treatments for everyone.
-
Assessing the impact of comorbidities on postoperative complications.
This study looks at how having other health issues affects the chances of complications after abdominal surgery to help doctors better understand and manage risks for their patients.
-
A large health study in Hamburg focusing on chronic diseases
This study is trying to find out what causes chronic diseases by looking at the health and lifestyle of 45,000 people aged 45 to 74 in Hamburg, Germany, and checking in with them over time.
-
Evaluating frailty in elderly patients undergoing heart procedures
This study looks at how frailty affects the recovery and outcomes of heart procedures in older patients aged 65 and up with coronary artery disease.
-
Registry of emotional stress in patients undergoing coronary interventions
This study looks at how emotional stress affects the long-term health of people with heart disease after they have heart procedures.
NIH-funded research (12)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Pay-what-you-can cafes and heart health in people with high blood pressure and food insecurity
This project tests whether eating at pay-what-you-can cafes improves blood pressure and heart- disease related outcomes for hypertensive adults who face food insecurity.
-
Apolipoprotein Proteoforms and Heart Health
This grant aims to understand how different chemical changes to apolipoproteins relate to cholesterol, obesity, insulin resistance, and risk of heart disease in people.
-
Metal exposures and heart disease: how genes and mixtures shape risk
A large study from NYU aims to understand how exposure to arsenic and other metals, together with genetic factors, influence the risk of coronary heart disease in diverse adults.
-
How stress-linked gene changes may raise heart disease risk
This project looks at whether stress-related chemical changes on DNA in blood immune cells help explain higher heart disease risk in people exposed to chronic psychosocial stress.
-
Genetic clues to blood fats and heart disease progression
Researchers are studying how genetic differences affect blood lipid levels and heart disease risk so doctors can tailor prevention for people at different ages.
-
PFAS chemicals, blood lipoproteins, and coronary heart disease risk
Researchers will look at whether common environmental chemicals called PFAS are linked to specific blood lipoproteins and higher risk of coronary heart disease in adults.
-
Metals and Heart Disease in Different Communities
This project looks at how exposure to different metals might affect heart health in various groups of people.
-
Investigating how environmental pollutants affect heart disease risk
This study is looking at how certain chemicals found in the environment might affect heart health, specifically how they could influence cholesterol levels and increase the risk of heart disease, and it invites people to share their health information and blood samples to help with this important research.
-
How stress affects heart disease through genetic changes
This study is looking at how stress affects heart health by checking changes in our DNA that might happen because of stress, and it's for anyone interested in understanding how stress could lead to heart problems.
-
How exposure to mixtures of toxic metals affects heart disease risk
This study is looking at how being around certain toxic metals, like arsenic, might affect your heart health, especially for people who may be more at risk for heart disease, and it aims to find out if being exposed to a mix of these metals is different from just being exposed to one at a time.
-
Using advanced models to predict stroke and heart disease risk
This study is working on creating personalized tools to help predict the risk of stroke and heart disease for people, so that those at higher risk can get more targeted care while others can be managed with less intensive treatments.
-
Investigating how gut microbes affect heart disease risk
This study is looking at how certain substances made by gut bacteria from the food we eat might affect the risk of heart disease, and it aims to find new ways to help prevent it for people from different backgrounds and diets.
Related topics
Quick answers
How many Coronary Heart Disease clinical trials are recruiting right now?
27, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 15 countries. The most sites are in China (12 trials), United States (2 trials), Finland (2 trials), Germany (2 trials), Italy (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 3, Early Phase 1: 1, Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.